Science Spotlight | Y Lim | June 18, 2018
The Clurman Lab, with collaborators from the Hutch, across the Pacific Northwest and abroad, theorized that pertinent biological insights into oncogenic mutations may be obtained via gene expression signatures that can predict the mutational status of a tumor for a specific gene in different tumor types.
Hutch News | Susan Keown | May 7, 2018
Algorithm illuminated surprising metabolic effects of important cancer gene.
Center News | Kristen Woodward | March 31, 2017
Awardees invited to compete for pilot funding in Immunotherapy Integrated Research Center grant competition.
Science Spotlight | J Herman | March 20, 2017
Ryan Davis, a graduate student in the Clurman Lab, recently found that the phosphatase PP2A-B56 plays a role in extending the lifetime of the S-phase associated cyclin E.
Center News | Rachel Tompa | October 18, 2016
Physician-scientist will focus on team science, interdisciplinary collaboration in pursuit of new cures.
Science Spotlight | A Neves | March 16, 2015
A recent Fred Hutch study led by Research Associate Dr. Hui Zhao in the lab of Dr. Jim Roberts (Basic Sciences Division), in collaboration with the lab of Dr. Bruce Clurman, (Human Biology and Clinical Research Divisions) and published in Oncotarget, sought to investigate the role of p27 in human breast cancer.
Science Spotlight | GMR Deyter | July 15, 2013
In a new manuscript published by the Clurman Lab in the Human Biology Division, lead author and postdoctoral fellow Dr. Bridget Hughes and colleagues deciphered the role that tight control of Cdk2 activity plays on cell cycle events.
Science Spotlight | JR Schoenborn | May 21, 2012
Drs. Jonathan Grim and Bruce Clurman and their colleagues in the Clinical Research Division have developed and characterized a new mouse model that recapitulates the key aspects of advanced stage disease.
Center's second major grant from the philanthropic foundation in recent weeks.